Forty Seven raises first half of $75mm Series A round; closes round
Stanford University spin-out Forty Seven Inc. raised the first half of a committed $75mm Series A round to fund its development work in immuno-oncology. Co-leads Lightspeed Venture Partners and Sutter Hill Ventures were joined by Clarus Ventures and GV (formerly Google Ventures) in the financing.
- Large Molecule
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com